Pfizer CEO says ‘not at all’ in favor of US patent waiver

BRUSSELS — Pfizer CEO Albert Bourla says he is against a US-backed proposal to waive patents on COVID-19 vaccines, saying production should be ramped up in existing facilities instead.

In an interview with AFP, Bourla says his company, which developed its vaccine with German firm BioNTech, is “not at all” in favor of the call from the United States to waive patent protections for coronavirus jabs.

Pfizer CEO Albert Bourla speaks during a press conference at Pfizer’s factory in Puurs, Belgium. (John Thys/Pool/AFP)

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.